ISS Stage III Plasma Cell Myeloma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00531 | Cyclophosphamide | 1 | Unknown Status | 1 |
| DB01073 | Fludarabine | 1 | Unknown Status | 1 |
| DB00480 | Lenalidomide | 1 | Unknown Status | 1 |
| DB00888 | Mechlorethamine | 1 | Unknown Status | 1 |
| DB00688 | Mycophenolate mofetil | 1 | Unknown Status | 1 |
| DB15721 | Natural Killer Cell | 1 | Unknown Status | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB00073 | Rituximab | 1 | Unknown Status | 1 |
| DB00864 | Tacrolimus | 1 | Unknown Status | 1 |
| DB17172 | Activated natural killer cell therapy | 2 | Recruiting | 1 |
| DB13906 | Aloe vera leaf | 2 | Recruiting | 1 |
| DB00126 | Ascorbic acid | 2 | Recruiting | 1 |
| DB01008 | Busulfan | 2 | Recruiting | 1 |
| DB17465 | CD-16 NK-92 cells | 2 | Recruiting | 1 |
| DB08889 | Carfilzomib | 2 | Recruiting | 1 |
| DB00631 | Clofarabine | 2 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
| DB09331 | Daratumumab | 2 | Recruiting | 1 |
| DB01234 | Dexamethasone | 2 | Recruiting | 1 |
| DB01073 | Fludarabine | 2 | Recruiting | 1 |
| DB09462 | Glycerin | 2 | Recruiting | 1 |
| DB00480 | Lenalidomide | 2 | Recruiting | 1 |
| DB00888 | Mechlorethamine | 2 | Recruiting | 1 |
| DB15721 | Natural Killer Cell | 2 | Recruiting | 1 |
| DB02701 | Nicotinamide | 2 | Recruiting | 1 |
| DB00073 | Rituximab | 2 | Recruiting | 1 |
| DB00162 | Vitamin A | 2 | Recruiting | 1 |